A randomized, double-blind, placebo-controlled study of the safety and tolerability of Study Drug and its effects on biomarkers in subjects with coronary artery disease.
Explore related content and topics
Blog
A Patient’s Perspective: Living with Type 1 Diabetes
Diabetes is a condition in which the body is unable to produce or properly utilize insulin, a hormone which is essential for energy production from…
Read Story
Page
Cardio-Metabolic
We’ve contributed to the successful approval of eight marketed cardiovascular and cardio-metabolic drugs.
Read More
Newsletter
Industry Watch
This week’s Industry Watch is covering better understanding of disease, from the relationship between COVID-19 and the gut - to the intersection of…
Read More
View all related content and resources for Cardio-Metabolic
Explore Insights